메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 25, Issue 5, 2007, Pages 605-606
Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice? [7]
Author keywords

[No Author keywords available]
Indexed keywords

CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CHRONOTHERAPY; CLINICAL PRACTICE; HUMAN; LETTER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; FEMALE; MALE; METHODOLOGY; MORTALITY; NOTE; PRACTICE GUIDELINE; SEX DIFFERENCE; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME;
EID: 33947539420     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.0365     Document Type: Letter
Times cited : (4)
References (4)
  • 1
    • 33747060772 scopus 로고    scopus 로고
    • Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group
    • Giacchetti S, Bjarnason G, Garufi C, et al: Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol 24:3562-3569, 2006
    • (2006) J Clin Oncol , vol.24 , pp. 3562-3569
    • Giacchetti, S.1    Bjarnason, G.2    Garufi, C.3
  • 2
    • 33645895554 scopus 로고    scopus 로고
    • The challenge of subgroup analyses-reporting without distorting
    • Lagakos SW: The challenge of subgroup analyses-reporting without distorting. N Engl J Med 354:1667-1669, 2006
    • (2006) N Engl J Med , vol.354 , pp. 1667-1669
    • Lagakos, S.W.1
  • 3
    • 0034799451 scopus 로고    scopus 로고
    • Subgroup analyses in randomized controlled trials: Quantifying the risks of false-positives and false-negatives
    • Brookes ST, Whitley E, Peters TJ, et al: Subgroup analyses in randomized controlled trials: Quantifying the risks of false-positives and false-negatives. Health Technol Assess 5:1-56, 2001
    • (2001) Health Technol Assess , vol.5 , pp. 1-56
    • Brookes, S.T.1    Whitley, E.2    Peters, T.J.3
  • 4
    • 1842453957 scopus 로고    scopus 로고
    • Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test
    • Brookes ST, Whitely E, Egger M, et al: Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol 57:229-236, 2004
    • (2004) J Clin Epidemiol , vol.57 , pp. 229-236
    • Brookes, S.T.1    Whitely, E.2    Egger, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.